Stock Analysis
- United States
- /
- Trade Distributors
- /
- NasdaqGM:TRNS
Craig Cairns Bought 22% More Shares In Transcat
Whilst it may not be a huge deal, we thought it was good to see that the Transcat, Inc. (NASDAQ:TRNS) Independent Director, Craig Cairns, recently bought US$92k worth of stock, for US$77.02 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 22%.
View our latest analysis for Transcat
Transcat Insider Transactions Over The Last Year
The President, Lee Rudow, made the biggest insider sale in the last 12 months. That single transaction was for US$1.6m worth of shares at a price of US$135 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$79.30. So it may not shed much light on insider confidence at current levels.
In total, Transcat insiders sold more than they bought over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.
Does Transcat Boast High Insider Ownership?
For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Insiders own 2.9% of Transcat shares, worth about US$21m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
What Might The Insider Transactions At Transcat Tell Us?
It's certainly positive to see the recent insider purchase. On the other hand the transaction history, over the last year, isn't so positive. We don't take much heart from transactions by Transcat insiders over the last year. But they own a reasonable amount of the company, and there was some buying recently. Overall they seem reasonably aligned. Of course, the future is what matters most. So if you are interested in Transcat, you should check out this free report on analyst forecasts for the company.
Of course Transcat may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Valuation is complex, but we're here to simplify it.
Discover if Transcat might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:TRNS
Transcat
Provides calibration and laboratory instrument services in the United States, Canada, and internationally.